Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Lieber

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Nature Biotechnology|September 2, 2003
AAV display--homing in on the targetAndré Lieber
FEBS Letters|November 19, 2013
Protein engineering to target complement evasion in cancerDarrick Carter, André Lieber
Current Opinion in Molecular Therapeutics|October 7, 2009
Anatomical and physical barriers to tumor targeting with oncolytic adenoviruses in vivoRobert Strauss, André Lieber
Journal of Virology|September 22, 2006
A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassetteHongjie Wang, André Lieber
FEBS Letters|November 10, 2019
Adenovirus vectors in hematopoietic stem cell genome editingChang Li, André Lieber
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2023
Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathiesAndré Lieber, Hans-Peter Kiem
Deutsches Arzteblatt International|November 18, 2021
Incomplete DescriptionAndré Lieber, Catharina Scheuermann-Poley
Methods in Molecular Medicine|July 28, 2007
Identifying functional adenovirus-host interactions using tandem mass spectrometryAnuj Gaggar, Dmitry Shayakhmetov, André Lieber
Genes|November 11, 2022
Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 VectorsMaximilian Richter, Hongjie Wang, André Lieber
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Analysis of EMT by flow cytometry and immunohistochemistryRobert Strauss, Jiri Bartek, André Lieber
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Nature Biotechnology|September 2, 2003
AAV display--homing in on the targetAndré Lieber
FEBS Letters|November 19, 2013
Protein engineering to target complement evasion in cancerDarrick Carter, André Lieber
Current Opinion in Molecular Therapeutics|October 7, 2009
Anatomical and physical barriers to tumor targeting with oncolytic adenoviruses in vivoRobert Strauss, André Lieber
Journal of Virology|September 22, 2006
A helper-dependent capsid-modified adenovirus vector expressing adeno-associated virus rep78 mediates site-specific integration of a 27-kilobase transgene cassetteHongjie Wang, André Lieber
FEBS Letters|November 10, 2019
Adenovirus vectors in hematopoietic stem cell genome editingChang Li, André Lieber
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2023
Prospects and challenges of in vivo hematopoietic stem cell genome editing for hemoglobinopathiesAndré Lieber, Hans-Peter Kiem
Deutsches Arzteblatt International|November 18, 2021
Incomplete DescriptionAndré Lieber, Catharina Scheuermann-Poley
Methods in Molecular Medicine|July 28, 2007
Identifying functional adenovirus-host interactions using tandem mass spectrometryAnuj Gaggar, Dmitry Shayakhmetov, André Lieber
Genes|November 11, 2022
Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 VectorsMaximilian Richter, Hongjie Wang, André Lieber
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2013
Analysis of EMT by flow cytometry and immunohistochemistryRobert Strauss, Jiri Bartek, André Lieber
Pageof 14